Moxie Dwight 4
4 · Revance Therapeutics, Inc. · Filed Sep 7, 2023
Insider Transaction Report
Form 4
Moxie Dwight
CLO & GC
Transactions
- Sale
Common Stock
2023-09-05$17.81/sh−23,853$424,920→ 55,066 total - Sale
Common Stock
2023-09-06$17.06/sh−11,000$187,704→ 44,066 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated June 05, 2023 by Mr. Moxie.
- [F2]The price reported in Table 1, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.44 to $18.20. Mr. Moxie undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Table 1, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.80 to $17.52. Mr. Moxie undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.